PRESS RELEASE: Sign Up for a Complimentary Inside Health Policy Trial
Contact: Steve Reilly
WASHINGTON, DC USA -- HEALTHCARE UPDATE NEWS SERVICE -- NOVEMBER 1, 2019: Sign up for a free trial subscription to Inside Health Policy, the online news service on health care policy from the regulatory reporting experts at Inside Washington Publishers. Your trial will simply expire at the end of 30 days. You don't have to do anything to stop your access.
HERE IS A SAMPLE OF THE LATEST INSIDE HEALTH POLICY DRUG PRICING STORIES THAT YOU CAN READ WITH YOUR FREE TRIAL:
Neal Wants Pelosi Drug Pricing Savings To Go To NIH, Pallone Unsure
House Ways & Means Chair Richard Neal (D-MA) wants some of the savings from House Speaker Nancy Pelosi's (D-CA) drug pricing plan to fund research at the National Institutes of Health, and said the change could be made in an amendment in the House Rules Committee. However, House Energy & Commerce Chair Frank Pallone (D-NJ), whose committee has jurisdiction over the issue, said he is unsure whether to allocate some savings to NIH.
Debate Over Int'l Drug Prices Overshadows Domestic Reference Pricing
Despite the focus on international prices, there is still debate over how to set uniform prices for therapeutically similar drugs. The Bipartisan Policy Center on Tuesday (Oct. 22) released a report analyzing approaches to both foreign and domestic reference pricing for controlling drug costs. Several countries in Europe combine versions of those approaches to set drug pay rates.
Doggett Gets Little Democratic Support For His Drug Price Amendments
Twelve hours after it started, the House Ways & Means Committee markup of Democrats' Medicare drug-price negotiation bill took an odd turn as health subcommittee Chair Lloyd Doggett (D-TX) failed to get but a few votes in support of his amendment to extend negotiated drug prices to the uninsured. Republicans, who had been at odds with Democrats all day, voted "present" for the measure.
You can try Inside Health Policy for the next month with absolutely no obligation. Your trial includes online access to the newsletter you choose: Inside CMS, FDA Week, Health Exchange Alert, or Inside Drug Pricing -- and please call us if you want access to a second newsletter with your trial. Plus, if you choose to subscribe, we'll offer you 50% off for the first year of access.
For more information about the 50% off, first-year savings, contact Steve Reilly at 703-562-8992, or e-mail him at firstname.lastname@example.org.